• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

World J Clin Cases . Increased levels of lactate dehydrogenase and hypertension are associated with severe illness of COVID-19

tetano

Editor, Senior Moderator
World J Clin Cases


. 2022 Jan 7;10(1):128-135.
doi: 10.12998/wjcc.v10.i1.128.
Increased levels of lactate dehydrogenase and hypertension are associated with severe illness of COVID-19


Zhen-Mu Jin[SUP] 1 [/SUP], Ji-Chan Shi[SUP] 2 [/SUP], Mo Zheng[SUP] 1 [/SUP], Que-Lu Chen[SUP] 3 [/SUP], Yue-Ying Zhou[SUP] 2 [/SUP], Fang Cheng[SUP] 2 [/SUP], Jing Cai[SUP] 2 [/SUP], Xian-Gao Jiang[SUP] 4 [/SUP]



Affiliations
Free PMC article

Abstract

Background: Coronavirus disease 2019 (COVID-19) is amid an ongoing pandemic. It has been shown that patients with cardiovascular comorbidities are at higher risk of severe illness of COVID-19.
Aim: To find out the relationship between cardiovascular comorbidities and severe illness of COVID-19.
Methods: The clinical data of 140 COVID-19 patients treated from January 22, 2020 to March 3, 2020 at our hospital were retrospectively collected. The clinical characteristics were compared between patients with mild illness and those with severe illness.
Results: There were 75 male patients and 65 female patients (53.6% vs 46.4%). The mean age was 45.4 ± 14.6 years (range, 2-85 years). Most of the patients had mild illness (n = 114, 81.4%) and 26 patients had severe illness (18.6%). The most common symptom was fever (n = 110, 78.6%), followed by cough (n = 82, 58.6%) and expectoration (n = 51, 36.4%). Eight patients were asymptomatic but were positive for severe acute respiratory syndrome coronavirus 2 RNA. Patients with severe illness were significantly more likely to be hypertensive than those with mild illness [(10/26, 38.4%) vs (22/114, 19.3%), P = 0.036]. The levels of lactate dehydrogenase were significantly higher in the severe illness group than in the mild illness group (299.35 ± 68.82 vs 202.94 ± 63.87, P < 0.001). No patient died in either the severe illness or the mild illness group.
Conclusion: Hypertension and elevated levels of lactate dehydrogenase may be associated with severe illness of COVID-19.

Keywords: COVID-19; Hypertension; Lactate dehydrogenase; Pneumonia; Radiology; Virus.
 
Back
Top Bottom